Insomnia Market Size, Trends Analysis and Growth Report 2023-2028

Industry Overview of Insomnia Market

Insomnia is a sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep, which can result in daytime fatigue and impaired functioning. It can be caused by worries and concerns that can keep the mind active, making it challenging to relax and fall asleep. It is affected by irregular sleep schedules, excessive caffeine or alcohol intake, and using electronic devices before bedtime. It is also responsible for sleep disturbances due to chronic pain, allergies, asthma, and conditions like restless leg syndrome. Moreover, irregular work hours disrupt the natural circadian rhythm of the body, making it difficult to establish a regular sleep pattern.

How Big Is the Insomnia Market?

The global insomnia market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3% during 2023-2028.

Request for a PDF sample of this report: https://www.imarcgroup.com/insomnia-market/requestsample

Insomnia Market Trends and Drivers:

Presently, insomnia is a pervasive issue affecting individuals across the globe. This high prevalence is compelling healthcare systems to prioritize insomnia treatment as a means of improving public health. Besides this, governing agencies and employers are recognizing the importance of addressing the issue of insomnia to enhance overall well-being and work efficiency. In addition, the increasing awareness about the close relationship between insomnia and mental health conditions, such as depression and anxiety, is highlighting the need for early diagnosis and treatment. This is spurring initiatives to provide accessible mental health support globally. Apart from this, ongoing scientific research is yielding a better understanding of insomnia's underlying causes and effective treatment options. This knowledge is encouraging healthcare providers to adopt evidence-based approaches. Moreover, the growing number of telehealth and digital health platforms is making insomnia treatment more accessible to individuals in remote or underserved areas. It enables the delivery of cognitive-behavioral therapy for insomnia (CBT-I) and other interventions online. In line with this, as lifestyle is becoming increasingly hectic and intertwined with global business and travel, managing insomnia is vital for individuals to adapt to changing time zones and work demands. Furthermore, the demographic shift is leading to the rising need for effective treatments to improve the sleep quality of older adults.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=6148&flag=C

Global Insomnia Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

The report segmented the market based on region, therapy type, drug class and distribution channel.

Breakup by Therapy Type:
• Non-Pharmacological Therapy
o Hypnotherapy
o Cognitive Behavioral Therapy
o Medical Devices
o Others
• Pharmacological Therapy
o Prescription Sleep Aids
o Over-The-Counter Sleep Aids

Breakup by Drug Class:
• Antidepressants
• Melatonin Antagonist
• Benzodiazepines
• Nonbenzodiazepines
• Orexin Antagonist
• Others

Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Breakup by Region:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.